Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • MD Brand Connect
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • MCI News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Aborad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
      • Medical Dialogues Show
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • MCI News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Aborad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • Industry Perspective
  • Home
  • AstraZeneca

Tag: AstraZeneca

You Searched For "astrazeneca"
AstraZeneca gets CDSCO Panel Nod to study asthma drug Benralizumab

AstraZeneca gets CDSCO Panel Nod to study asthma drug Benralizumab

Dr. Divya Colin22 Sep 2023 12:30 PM GMT
New Delhi: Pharmaceutical major, AstraZeneca has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
AstraZeneca rare disease unit acquires Pfizer portfolio for USD 1 billion

AstraZeneca rare disease unit acquires Pfizer portfolio for USD 1 billion

Ruchika Sharma22 Sep 2023 8:55 AM GMT
AstraZeneca's Rare-Disease Unit
AstraZeneca Enhertu recommended for nod in EU by CHMP for HER2-mutant advanced non-small cell lung cancer

AstraZeneca Enhertu recommended for nod in EU by CHMP for HER2-mutant advanced non-small cell lung cancer

Ruchika Sharma16 Sep 2023 8:00 AM GMT
Cambridge: AstraZeneca and Daiichi Sankyo’s (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for...
AstraZeneca seeks to calm CEO speculation after shares drop

AstraZeneca seeks to calm CEO speculation after shares drop

Ruchika Sharma12 Sep 2023 11:00 AM GMT
London: AstraZeneca appeared to play down speculation about the future of its CEO after its shares fell more than 4% on Monday following a...
AstraZeneca declares positive results from trial of Tagrisso plus chemotherapy to treat EGFR-mutated advanced lung cancer

AstraZeneca declares positive results from trial of Tagrisso plus chemotherapy to treat EGFR-mutated advanced lung cancer

Ruchika Sharma12 Sep 2023 8:00 AM GMT
Cambridge: AstraZeneca has announced positive results from FLAURA2 phase III trial of Tagrisso (osimertinib) in combination with chemotherapy for...
Alveoair spirometer earns USFDA clearance for distribution in US

Alveoair spirometer earns USFDA clearance for distribution in US

Ruchika Sharma9 Sep 2023 10:24 AM GMT
Pune: Alveofit (Roundworks Technologies Private Limited) has announced that its groundbreaking product, alveoair spirometer, has earned U.S. FDA...
AstraZeneca Calquence approved in China for chronic lymphocytic leukaemia

AstraZeneca Calquence approved in China for chronic lymphocytic leukaemia

Ruchika Sharma5 Sep 2023 6:25 AM GMT
Cambridge: AstraZeneca’s Calquence (acalabrutinib), a next generation, selective Bruton’s tyrosine kinase (BTK) inhibitor, has been approved in...
AstraZeneca-Daiichi Sankyo Enhertu gets two breakthrough therapy designations in US for multiple HER2 expressing cancers

AstraZeneca-Daiichi Sankyo Enhertu gets two breakthrough therapy designations in US for multiple HER2 expressing cancers

Ruchika Sharma3 Sep 2023 10:30 AM GMT
Tokyo: Daiichi Sankyo has announced that ENHERTU (fam-trastuzumab deruxtecan-nxki) has been granted two additional Breakthrough Therapy Designations...
AstraZeneca Soliris approved in Japan for paediatric patients with generalised myasthenia gravis

AstraZeneca Soliris approved in Japan for paediatric patients with generalised myasthenia gravis

Ruchika Sharma29 Aug 2023 10:44 AM GMT
Cambridge: AstraZeneca's Soliris (eculizumab) has been approved in Japan for expanded use to include the treatment of generalised myasthenia gravis...
AstraZenecas Lynparza plus abiraterone approved in Japan for treatment of BRCA-mutated metastatic castration-resistant prostate cancer

AstraZeneca's Lynparza plus abiraterone approved in Japan for treatment of BRCA-mutated metastatic castration-resistant prostate cancer

Ruchika Sharma26 Aug 2023 6:00 AM GMT
Cambridge: AstraZeneca and MSD’s Lynparza (olaparib) in combination with abiraterone and prednisolone has been approved in Japan for the treatment of...
AstraZeneca facing two London lawsuits over COVID vaccines

AstraZeneca facing two London lawsuits over COVID vaccines

Ruchika Sharma24 Aug 2023 6:07 AM GMT
The two cases are the first lawsuits brought in England and Wales over an adverse reaction to a COVID 19 vaccine, according to publicly available...
AstraZeneca Forxiga approved in China to reduce cardiovascular death, hospitalisation risk in adults with symptomatic chronic heart failure

AstraZeneca Forxiga approved in China to reduce cardiovascular death, hospitalisation risk in adults with symptomatic chronic heart failure

Ruchika Sharma20 Aug 2023 8:00 AM GMT
Forxiga is a first-in-class, oral, once-daily selective inhibitor of human sodium-glucose co-transporter 2 (SGLT2).
Next

Editorial

Journal Club Today

Health News Today

© 2022 All Rights Reserved.
Powered By: Hocalwire
X